Review uncovers drug resistance mechanisms in Mycobacterium tuberculosis, highlighting vaccine development challenges, implying urgency for new strategies.
Key Points
This review aims to synthesize the mechanisms of drug resistance in Mycobacterium tuberculosis and the challenges faced in vaccine development.
Reviewed existing literature on drug resistance mechanisms in Mycobacterium tuberculosis.
Analyzed challenges in developing effective vaccines against drug-resistant tuberculosis.
Discussed novel therapeutic strategies and vaccine candidates.
Identified multiple drug resistance mechanisms including cell wall remodeling and metabolic changes.
Highlighted the limited efficacy of current vaccines like Bacillus Calmette-Guérin.
Outlined potential next-generation vaccine candidates and therapeutic strategies, such as bedaquiline and host-directed therapies.